Bristol-Myers Squibb Co (NYSE:BMY)
| 66.85 BATS BZX Real-Time Price As of 10:16am ET |  +0.13 / +0.19%Today’s Change | 42.48 Today|||52-Week Range 67.21 | +4.14% Year-to-Date |
Latest BMY News | Press Releases
| 3 Attractive Dividend Stocks Whose Dividends Could Double Jan 19 / MotleyFool.com - Paid Partner Content | All the 2020 Pre-JPM News Healthcare Investors Need to Know Jan 11 / MotleyFool.com - Paid Partner Content |
| FDA Advisory Committee Slams Nektar's New Opioid Drug Jan 15 / MotleyFool.com - Paid Partner Content | Here's Why Nektar Therapeutics Shares Rose as Much as 19.7% Today Jan 10 / MotleyFool.com - Paid Partner Content |
| Why Nektar Therapeutics Stock Is Sinking Today Jan 15 / MotleyFool.com - Paid Partner Content | Bristol-Myers Squibb's Celgene Unit Backs Out of a $55 Million Settlement Jan 09 / MotleyFool.com - Paid Partner Content |
| 2020 J.P. Morgan Healthcare Conference Roundup Jan 13 / MotleyFool.com - Paid Partner Content | The Risk of Cancer-Related Death Is Dropping Faster Than Ever Jan 08 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 66.72 |
| Today’s open | 66.70 |
| Day’s range | 66.54 - 67.19 |
| Volume | 1,959,872 |
| Average volume (3 months) | 15,969,653 |
| Market cap | $156.4B |
Data as of 10:16am ET, 01/21/2020
Growth & Valuation
| Earnings growth (last year) | +392.14% |
| Earnings growth (this year) | +10.18% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 19.4 |
| Price/Sales | 3.77 |
| Price/Book | 7.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.40 | -0.78% |
| LLYEli Lilly and Co | +0.48 | +0.34% |
| ABBVAbbVie | +0.02 | +0.02% |
| SNYSanofi | -0.44 | -0.86% |
Data as of 10:16am ET, 01/21/2020
Financials
| Next reporting date | January 27, 2020 |
| EPS forecast (this quarter) | $0.89 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
